Investment
Features
FeesSafety
Academy
More
Pluang+

Bitcoin ETFs rebound with $176M inflows led by Fidelity and Blackrock, while Ether ends 10-day outflow streak.

Market News
14 Oct 2026
Bitcoin
View Source
Bullish
Bitcoin ETFs rebound with $176M inflows led by Fidelity and Blackrock, while Ether ends 10-day outflow streak.

Bitcoin ETFs saw a strong rebound on Tuesday with $175.62 million in inflows, driven by Fidelity's $103 million and Blackrock's $66 million, reversing recent heavy outflows. Ether ETFs also ended a 10-session losing streak, attracting $24.84 million, signaling renewed institutional interest. However, Solana and Zcash ETFs continued to face outflows, indicating selective investor confidence. The recovery in Bitcoin and Ether inflows may mark the start of broader institutional stabilization in crypto ETFs if sustained.

Bitcoin ETFs and institutional inflows are the focus of recent market interest. For readers following the broader cryptocurrency market, here is Pluang's market snapshot as of Oct 14, 2026 18:31 WIB: Among 50 major cryptocurrencies, 24 rose and 25 fell today. Notable movers include BCH (Bitcoin Cash) at Rp4.974.029 with a 1-day change of +2.60% and Pluang order activity of 41% Sell / 59% Buy, COTI at Rp218 with -2.29% change and 25% Sell / 75% Buy activity, and ALGO (Algorand) at Rp2.155 with +2.28% change and 44% Sell / 56% Buy activity. Typical hold times range from 69 to 130 days on Pluang.

More News

CodeWall raises $4M to launch AI-driven autonomous attack agents for continuous enterprise security testing.

CodeWall raises $4M to launch AI-driven autonomous attack agents for continuous enterprise security testing.

CodeWall Ltd. has emerged from stealth with $4 million in pre-seed funding to develop AI-powered autonomous attack agents that simulate real-world cyberattacks on enterprises. These agents start from outside the network with no insider access, contin...

Others
Bullish
24 minutes ago
Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics has appointed John O’Malley, M.D., Ph.D., as its Chief Medical Officer. Dr. O’Malley brings extensive experience in immunology and clinical development from his previous roles at CRISPR Therapeutics and Sanofi. His leadership ...

Market News
Bullish
1 hour ago
FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

Orvida Pharma announced that the FDA has accepted its lead drug candidate KM-023 (ontivatrep) into the Rare Disease Evidence Principles (RDEP) process for treating Olmsted syndrome, a rare genetic skin disorder. This acceptance allows Orvida to engag...

Market News
Bullish
1 hour ago
DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global Inc. will announce its financial results for the third quarter ending September 30, 2026, on October 27 after the stock market closes. The company will hold a conference call and webcast to discuss the results, providing investors with ins...

Company Fundamentals
Neutral
1 hour ago
Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware introduced its Model Context Protocol (MCP) Server Protection solution to help organizations secure the integration layer where AI agents connect to enterprise applications and workflows. This new security tool provides visibility into MCP in...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App